To prove a role for CTSL in KDM4C-blockade-induced histone clipping, we deleted CTSL in five basal breast cancer cell lines (three KDM4C-amplified and two non-amplified) using CRISPR–Cas9 (Extended Data Fig. 6a). Here, CTSL is linked to breast carcinoma.